Epitope OraQuick On-Site HIV Test U.S. Trials Expected To Start In July
This article was originally published in The Gray Sheet
Executive Summary
Epitope, Inc. says it will submit a premarket approval application for its OraQuick non-invasive, rapid, oral-fluid HIV-1/2 antibody test in January 2001.